Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $19.00 Consensus Target Price from Analysts

Shares of Lexeo Therapeutics, Inc. (NASDAQ: LXEO - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the ten brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, eight have issued a buy recommendation and one has assigned a strong buy